Kinase drug discovery approaches in chronic myeloproliferative disorders.

Abstract:

:Myeloproliferative disorders (MPDs) are clonal malignancies that arise from hematopoietic progenitors and characterized by overproduction of mature, functional blood cells. These disorders can be broadly characterized into Philadelphia chromosome-positive (Ph(+)) or negative (Ph(-)) genetic groupings. Chronic myeloid leukemia (CML) is a Ph(+) MPD that is defined on the basis of its molecular lesion, the BCR-ABL fusion gene. Inhibitors directed at the constitutive kinase activity of BCR-ABL have been shown to be disease modifying in CML and have dramatically altered the standard of care for this leukemia. The three main Ph(-) MPDs are polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). The key features of these Ph(-) MPDs are an increased red blood cell mass in PV, a high platelet count in ET and bone marrow fibrosis in PMF, respectively. These disorders also share many clinical features such as long clinical course, increased risk for thrombosis, hemorrhage and elevated risk of leukemic transformation. Interest in these disorders has been ignited by the recent discovery of activating mutations in the tyrosine kinase gene, JAK2, in the predominance of Ph(-) MPD patients and has highlighted JAK2 as a therapeutic intervention point for drug discovery efforts with selective kinase inhibitors. This review will focus on the comparison of Ph(+) and Ph(-) MPDs, drug discovery and development efforts targeting these disorders, and will assess the new opportunities for targeted therapies for these diseases.

journal_name

Oncogene

journal_title

Oncogene

authors

Kumar C,Purandare AV,Lee FY,Lorenzi MV

doi

10.1038/onc.2009.107

subject

Has Abstract

pub_date

2009-06-18 00:00:00

pages

2305-13

issue

24

eissn

0950-9232

issn

1476-5594

pii

onc2009107

journal_volume

28

pub_type

杂志文章,评审

相关文献

ONCOGENE文献大全
  • Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.

    abstract::Tbx3 is a member of the T-box family of transcription factors. Mutations in Tbx3 cause ulnar-mammary syndrome, an autosomal dominant disorder characterized by upper limb defects, apocrine-gland defects including mammary hypoplasia, and tooth, hair and genital defects. In cell culture, Tbx3 and its close relative Tbx2 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205476

    authors: Carlson H,Ota S,Song Y,Chen Y,Hurlin PJ

    更新日期:2002-05-30 00:00:00

  • Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy.

    abstract::The p53 oncosuppressor is strictly maintained in an inactive form under normal conditions, while it is post-translationally activated by a variety of stresses, enacting different protective biological functions. Since one critical issue in cancer gene therapy is tumor specificity, we asked whether the tight p53 regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207042

    authors: Bossi G,Mazzaro G,Porrello A,Crescenzi M,Soddu S,Sacchi A

    更新日期:2004-01-15 00:00:00

  • Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR.

    abstract::Neuroblastoma is the second most common pediatric malignancy, characterized by a high rate of unexplained spontaneous remissions. Much progress has been made in understanding neuroblastoma differentiation triggered by certain agents such as retinoic acid. However, little is known about the signalling pathways that lea...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208494

    authors: Evangelopoulos ME,Weis J,Krüttgen A

    更新日期:2005-05-05 00:00:00

  • MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.

    abstract::MicroRNAs (miRNAs) make up a novel class of gene regulators; they function as oncogenes or tumor suppressors by targeting tumor-suppressor genes or oncogenes. A recent study that analysed a large number of human cancer cell lines showed that miR-330 is a potential tumor-suppressor gene. However, the function and molec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.192

    authors: Lee KH,Chen YL,Yeh SD,Hsiao M,Lin JT,Goan YG,Lu PJ

    更新日期:2009-09-24 00:00:00

  • Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53.

    abstract::The p53 tumour suppressor induces cell cycle arrest and apoptosis in response to cellular stresses. p53 is inactivated by various cellular and viral factors. We set out to generate regulatable p53 derivatives that are highly inducible by synthetic ligands, escape inactivation and efficiently induce apoptosis. We have ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203256

    authors: Sengupta S,Ralhan R,Wasylyk B

    更新日期:2000-01-20 00:00:00

  • Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism.

    abstract::Hec1 (highly expressed in cancer 1) or Nek2 (NIMA-related kinase 2) is often overexpressed in cancers with poor prognosis. Both are critical mitotic regulators, and phosphorylation of Hec1 S165 by Nek2 is required for proper chromosome segregation. Therefore, inactivation of Hec1 and Nek2 by targeting their interactio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.67

    authors: Hu CM,Zhu J,Guo XE,Chen W,Qiu XL,Ngo B,Chien R,Wang YV,Tsai CY,Wu G,Kim Y,Lopez R,Chamberlin AR,Lee EY,Lee WH

    更新日期:2015-03-05 00:00:00

  • Murine WNT11 is a secreted glycoprotein that morphologically transforms mammary epithelial cells.

    abstract::Wnt genes encode a set of structurally related cell surface glycoproteins that appear to have roles in cell-cell signalling. The ectopic expression of several murine Wnt genes has been implicated in the transformation of mammary epithelial and the onset of mammary tumours. Wnt11 is expressed in the developing embryo i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Christiansen JH,Monkley SJ,Wainwright BJ

    更新日期:1996-06-20 00:00:00

  • Loss of a single Hic1 allele accelerates polyp formation in Apc(Δ716) mice.

    abstract::Adenomatous polyposis coli (APC) gene mutations have been implicated in familial and sporadic gastrointestinal (GI) cancers. APC mutations are associated with autosomal dominant inheritance of disease in humans. Similarly, mice that contain a single mutant APC gene encoding a protein truncated at residue 716 (Apc(Δ716...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.633

    authors: Mohammad HP,Zhang W,Prevas HS,Leadem BR,Zhang M,Herman JG,Hooker CM,Watkins DN,Karim B,Huso DL,Baylin SB

    更新日期:2011-06-09 00:00:00

  • Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance.

    abstract::High CD44 expression is associated with enhanced malignant potential in esophageal squamous cell carcinoma (ESCC), among the deadliest of all human carcinomas. Although alterations in autophagy and CD44 expression are associated with poor patient outcomes in various cancer types, the relationship between autophagy and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.102

    authors: Whelan KA,Chandramouleeswaran PM,Tanaka K,Natsuizaka M,Guha M,Srinivasan S,Darling DS,Kita Y,Natsugoe S,Winkler JD,Klein-Szanto AJ,Amaravadi RK,Avadhani NG,Rustgi AK,Nakagawa H

    更新日期:2017-08-24 00:00:00

  • Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression.

    abstract::Sex-determining region Y box 6 (SOX6) has been described as a tumor-suppressor gene in several cancers. Our previous work has suggested that SOX6 upregulated p21(Waf1/Cip1)(p21) expression in a p53-dependent manner; however, the underlying mechanism has remained elusive. In this study, we confirmed that SOX6 can suppr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.234

    authors: Wang J,Ding S,Duan Z,Xie Q,Zhang T,Zhang X,Wang Y,Chen X,Zhuang H,Lu F

    更新日期:2016-03-31 00:00:00

  • LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.

    abstract::Liver tumor-initiating cells (TICs), the drivers for liver tumorigenesis, accounts for liver tumor initiation, metastasis, drug resistance and relapse. Wnt/β-catenin signaling pathway emerges as a critical modulator in liver TIC self-renewal. However, the molecular mechanism of Wnt/β-catenin initiation in liver tumori...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0203-6

    authors: Chen Z,Gao Y,Yao L,Liu Y,Huang L,Yan Z,Zhao W,Zhu P,Weng H

    更新日期:2018-06-01 00:00:00

  • Overexpression confers an oncogenic potential upon the eph gene.

    abstract::The eph gene encodes a putative receptor tyrosine kinase for an as yet unknown ligand. Some human cancer cells have been found to overexpress eph mRNAs without gene amplification. We show here that NIH3T3 cells acquire tumorigenic ability in nude mice and make colonies in soft agar with a viral LTR (Long Terminal Repe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maru Y,Hirai H,Takaku F

    更新日期:1990-03-01 00:00:00

  • Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.

    abstract::The Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) has a significant role in initiating EBV-associated lymphoproliferative disease and EBV-related malignancies. In view of clinical features related to the type of EBV latency, LMP1 may influence invasiveness of EBV associated tumors categorized as ty...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203502

    authors: Kim KR,Yoshizaki T,Miyamori H,Hasegawa K,Horikawa T,Furukawa M,Harada S,Seiki M,Sato H

    更新日期:2000-03-30 00:00:00

  • Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.

    abstract::Hepatitis B virus (HBV)-induced liver necrosis takes great part in liver cirrhosis progression. However, less is known about whether hepatitis B virus X protein (HBx) has effect on liver fibrosis. Here, we report that HBV leads to liver fibrosis and hepatocarcinogenesis through miR-30e targeting P4HA2. HBV transgenic ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.291

    authors: Feng GX,Li J,Yang Z,Zhang SQ,Liu YX,Zhang WY,Ye LH,Zhang XD

    更新日期:2017-12-14 00:00:00

  • Tumor suppressor activity of RUNX3.

    abstract::Recent analyses have revealed that RUNX family members play important roles in both normal developmental processes and carcinogenesis. Of the three known RUNX family members, RUNX3 has been shown to be involved in neurogenesis of the dorsal root ganglia, T-cell differentiation and tumorigenesis of gastric epithelium. ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207286

    authors: Bae SC,Choi JK

    更新日期:2004-05-24 00:00:00

  • Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis.

    abstract::To identify genes that are differentially over-expressed in Small Cell Lung Carcinoma (SCLC) we have used a combination of suppression subtractive hybridization and cDNA microarray to analyse the expression profiles of 2400 cDNAs clones. Genes that are over-expressed in SCLC were identified using 32 pairs of fluoresce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205480

    authors: Bangur CS,Switzer A,Fan L,Marton MJ,Meyer MR,Wang T

    更新日期:2002-05-23 00:00:00

  • EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.579

    authors: Wu J,Patmore DM,Jousma E,Eaves DW,Breving K,Patel AV,Schwartz EB,Fuchs JR,Cripe TP,Stemmer-Rachamimov AO,Ratner N

    更新日期:2014-01-09 00:00:00

  • Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas.

    abstract::Many chromosomal regions undergo loss of heterozygosity (LOH) in ovarian adenocarcinomas but few of the target regions have been finely mapped. One of the chromosome arms likely to harbour one or more tumour suppressor genes inactivated in ovarian cancer is the short arm of chromosome 8 which is frequently deleted in ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202028

    authors: Wright K,Wilson PJ,Kerr J,Do K,Hurst T,Khoo SK,Ward B,Chenevix-Trench G

    更新日期:1998-09-03 00:00:00

  • Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.

    abstract::The mechanisms by which the p53 tumour suppressor protein would, in vivo, co-ordinate the adaptive response to genotoxic stress is poorly understood. p53 has been shown to transactivate several genes that could be involved in two main cellular responses, growth arrest and apoptosis. To get further insight into the tis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203366

    authors: Bouvard V,Zaitchouk T,Vacher M,Duthu A,Canivet M,Choisy-Rossi C,Nieruchalski M,May E

    更新日期:2000-02-03 00:00:00

  • Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.

    abstract::Matrix metalloprotease-1 (MMP1) is an important mediator of tumorigenesis, inflammation and tissue remodeling through its ability to degrade critical matrix components. Recent studies indicate that stromal-derived MMP1 may exert direct oncogenic activity by signaling through protease-activated receptor-1 (PAR1) in car...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.157

    authors: Foley CJ,Fanjul-Fernández M,Bohm A,Nguyen N,Agarwal A,Austin K,Koukos G,Covic L,López-Otín C,Kuliopulos A

    更新日期:2014-04-24 00:00:00

  • WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential.

    abstract::We have isolated a gene (WS5) that is specifically expressed at the mRNA and protein level in avian fibroblasts transformed by the v-myc oncogene of avian acute leukemia virus MC29. In a conditional cell transformation system, WS5 gene expression was tightly correlated with v-myc activation. The WS5 gene contains 11 e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209975

    authors: Reiter F,Hartl M,Karagiannidis AI,Bister K

    更新日期:2007-03-15 00:00:00

  • Na+,HCO3--cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice.

    abstract::Metabolic acid production challenges cellular pH homeostasis in solid cancer tissue, and mechanisms of net acid extrusion represent promising new targets for breast cancer therapy. Here, we used genetically engineered mice to investigate the contribution of the Na+,HCO3--cotransporter NBCn1 (Slc4a7) to intracellular a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0353-6

    authors: Lee S,Axelsen TV,Jessen N,Pedersen SF,Vahl P,Boedtkjer E

    更新日期:2018-10-01 00:00:00

  • Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling.

    abstract::The cellular and molecular mechanisms of tumor progression following chemotherapy are largely unknown. Here, we demonstrate that cisplatin (CDDP) treatment upregulates VEGF and Flt1 expression leading to the survival and expansion of a highly tumorigenic fraction of side-population (SP) cells in osteosarcoma (HOS), ne...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.38

    authors: Tsuchida R,Das B,Yeger H,Koren G,Shibuya M,Thorner PS,Baruchel S,Malkin D

    更新日期:2008-06-26 00:00:00

  • Ecotropic viral integration site 1, a novel oncogene in prostate cancer.

    abstract::Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer in men in the western world. Mutations in tumor suppressor genes and in oncogenes are important for PCa progression, whereas the role of stem cell proteins in prostate carcinogenesis is insufficiently examined. This study investigates the role o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.325

    authors: Queisser A,Hagedorn S,Wang H,Schaefer T,Konantz M,Alavi S,Deng M,Vogel W,von Mässenhausen A,Kristiansen G,Duensing S,Kirfel J,Lengerke C,Perner S

    更新日期:2017-03-01 00:00:00

  • From identification of the BTK kinase to effective management of leukemia.

    abstract::BTK is a cytoplasmic protein-tyrosine kinase, whose corresponding gene was isolated in the early 1990s. BTK was initially identified by positional cloning of the gene causing X-linked agammaglobulinemia and independently in a search for new kinases. Given the phenotype of affected patients, namely lack of B-lymphocyte...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.343

    authors: Smith CI

    更新日期:2017-04-01 00:00:00

  • Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes.

    abstract::Genetic analysis of beta-catenin-induced oncogenic transformation in chicken embryo fibroblasts (CEF) revealed the following prerequisites for oncogenicity: (1) removal of the N terminal phosphorylation sites targeted by glycogen synthase kinase 3beta (GSK3beta), (2) retention of the N terminal transactivation domain,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205796

    authors: Aoki M,Sobek V,Maslyar DJ,Hecht A,Vogt PK

    更新日期:2002-10-10 00:00:00

  • Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

    abstract::Alternative splicing is a widespread process contributing to structural transcript variation and proteome diversity. In cancer, the splicing process is commonly disrupted, resulting in both functional and non-functional end-products. Cancer-specific splicing events are known to contribute to disease progression; howev...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.318

    authors: Sveen A,Kilpinen S,Ruusulehto A,Lothe RA,Skotheim RI

    更新日期:2016-05-12 00:00:00

  • Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.

    abstract::Fallopian tube carcinoma (FTC) is a rare, poorly studied and aggressive cancer, associated with poor survival. Since tumorigenesis is related to the acquisition of genetic changes, we used genome-wide array comparative genomic hybridization to analyse copy number aberrations occurring in FTC in order to obtain a bette...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206621

    authors: Snijders AM,Nowee ME,Fridlyand J,Piek JM,Dorsman JC,Jain AN,Pinkel D,van Diest PJ,Verheijen RH,Albertson DG

    更新日期:2003-07-03 00:00:00

  • Apoptosis signaling triggered by the marine alkaloid ascididemin is routed via caspase-2 and JNK to mitochondria.

    abstract::The marine alkaloid ascididemin (ASC) was shown to exert cytotoxicity even against multidrug-resistant cancer cells. Here, we address the signaling pathways utilized by ASC to trigger apoptosis in Jurkat leukemia T cells. We show that ASC (0.5-20 microM) induces a mitochondrial pathway that requires the activation of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207281

    authors: Dirsch VM,Kirschke SO,Estermeier M,Steffan B,Vollmar AM

    更新日期:2004-02-26 00:00:00

  • Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.

    abstract::Inherited mutations in the BRCA1 gene confer increased susceptibility to breast and ovarian cancer. Its role in sporadic carcinogenesis is not well defined. Somatic mutations in breast cancers have not been reported and to date there are only three reports of somatic mutations in sporadic ovarian cancers. To investiga...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202847

    authors: Khoo US,Ozcelik H,Cheung AN,Chow LW,Ngan HY,Done SJ,Liang AC,Chan VW,Au GK,Ng WF,Poon CS,Leung YF,Loong F,Ip P,Chan GS,Andrulis IL,Lu J,Ho FC

    更新日期:1999-08-12 00:00:00